Skip to main content
Log in

The pattern of thyroid function of subclinical hypothyroid women with levothyroxine treatment during pregnancy

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

In this study, we researched the pattern of thyroid function of subclinical hypothyroid (SCH) women with levothyroxine (LT4) throughout pregnancy and determined the optimal dosages of LT4 for such women. 56 SCH pregnant women were followed regularly prospectively. They were divided into three groups: group A (n = 29. Baseline TSH between 2.5 and 5.0 mIU/L) received 50 μg/day of LT4; group B (n = 17. Baseline TSH between 5.0 and 8.0 mIU/L) received 75 μg/day of L-T4; group C (n = 10. Baseline TSH >8.0 mIU/L) received 100 μg/day of LT4. All the patients started LT4 therapy around the 8th gestational week. Serum TSH, free T4, and free T3 were measured at 4-week intervals throughout pregnancy. Among the thyroid function indexes, serum TSH changed quickly and decreased significantly 4 weeks after LT4 therapy. The change of serum FT4 responded drastically at the 12th gestational week. We also found that serum FT3 did not change much after LT4 therapy. 50, 75, and 100 μg/day can maintain serum TSH level of 79.3, 82.4, and 90.0 % of SCH women in definitive therapeutic goal in group A, B, and C, respectively. The LT4 dose need to be adjusted one or more times in 20.7, 17.6, and 10.0 % of the SCH women in group A, B, and C, respectively. The different LT4 dose can be chosen according to the baseline TSH levels of SCH women. The constant LT4 dose can maintain serum TSH levels of 79.3–90 % patients in the ideal range. A small part of patients require adjust therapy also during the second and third trimester. Therefore, careful follow-up of SCH pregnant women should be taken, and thyroid function should be tested every month until the end of pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. J.E. Haddow, G.E. Palomaki, W.C. Allan, J.R. Williams, G.J. Knight, J. Gagnon, C.E. O’Heir, M.L. Mitchell, R.J. Hermos, S.E. Waisbren, J.D. Faix, R.Z. Klein, Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N. Engl. J. Med. 341, 549–555 (1999)

    Article  PubMed  CAS  Google Scholar 

  2. V.J. Pop, J.L. Kuijpens, A.L. van Baar, G. Verkerk, M.M. van Son, J.J. de Vijlder, T. Vulsma, W.M. Wiersinga, H.A. Drexhage, H.L. Vader, Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin. Endocrinol. (Oxf.) 50, 149–155 (1999)

    Article  CAS  Google Scholar 

  3. V.J. Pop, E.P. Brouwers, H.L. Vader, T. Vulsma, A.L. van Baar, J.J. de Vijlder, Maternal hypothyroxinaemia during early pregnancy and subsequent child development: a 3 year follow-up study. Clin. Endocrinol. (Oxf.) 59, 282–288 (2003)

    Article  Google Scholar 

  4. W.C. Allan, J.E. Haddow, G.E. Palomaki, J.R. Williams, M.L. Mitchell, R.J. Hermos, J.D. Faix, R.Z. Klein, Maternal thyroid deficiency and pregnancy complications: implications for population screening. J. Med. Screen 7, 127–130 (2000)

    Article  PubMed  CAS  Google Scholar 

  5. B.M. Casey, J.S. Dashe, C.E. Wells, D.D. McIntire, W. Byrd, K.J. Leveno, Cunningham FG subclinical hypothyroidism and pregnancy outcomes. Obstet. Gynecol. 105, 239–245 (2005)

    Article  PubMed  Google Scholar 

  6. A. Stagnaro-Green, X. Chen, J.D. Bogden, T.F. Davies, T.O. Scholl, The thyroid and pregnancy: a novel risk factor for very preterm delivery. Thyroid 15, 351–357 (2005)

    Article  PubMed  CAS  Google Scholar 

  7. P.Y. Su, K. Huang, J.H. Hao, Y.Q. Xu, S.Q. Yan, T. Li, Y.H. Xu, F.B. Tao, Maternal thyroid function in the first 20 weeks of pregnancy and subsequent fetal and infant development: a prospective population-based cohort study in china. J. Clin. Endocrinol. Metab. 96, 3234–3241 (2011)

    Article  PubMed  CAS  Google Scholar 

  8. S.M. Reid, P. Middleton, M.C. Cossich, C.A. Crowther, Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database Syst. Rev. 7, CD007752 (2010)

    PubMed  Google Scholar 

  9. M. Abalovich, N. Amino, L.A. Barbour, R.H. Cobin, L.J. De Groot, D. Glinoer, S.J. Mandel, A. Stagnaro-Green, Management of thyroid dysfunction during pregnancy and postpartum: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 92, S1–S47 (2007)

    Article  PubMed  CAS  Google Scholar 

  10. A. Stagnaro-Green, M. Abalovich, E. Alexander, F. Azizi, J. Mestman, R. Negro, A. Nixon, E.N. Pearce, O.P. Soldin, S. Sullivan, W. Wiersinga, American thyroid association taskforce on thyroid disease during pregnancy and postpartum. Guidelines of the American thyroid association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21, 1081–1125 (2011)

    Article  PubMed  Google Scholar 

  11. C. De Geyter, S. Steimann, B. Müller, M.E. Kränzlin, C. Meier, Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxine is similar to that in euthyroid controls. Thyroid 19, 53–59 (2009)

    Article  PubMed  Google Scholar 

  12. U. Verga, S. Bergamaschi, D. Cortelazzi, S. Ronzoni, A.M. Marconi, P. Beck-Peccoz, Adjustment of L-T4 substitutive therapy in pregnant women with subclinical, overt or post-ablative hypothyroidism. Clin. Endocrinol. (Oxf.) 70, 798–802 (2009)

    Article  CAS  Google Scholar 

  13. J.H. Lazarus, J.P. Bestwick, S. Channon, R. Paradice, A. Maina, R. Rees, E. Chiusano, R. John, V. Guaraldo, L.M. George, M. Perona, D. Dall’Amico, A.B. Parkes, M. Joomun, N.J. Wald, Antenatal thyroid screening and childhood cognitive function. N. Engl. J. Med. 366, 493–501 (2012)

    Article  PubMed  CAS  Google Scholar 

  14. I. Seoane Cruz, M. Penín Álvarez, R. Luna Cano, R.V. García-Mayor, Treatment with fixed thyroxine doses in pregnant women with subclinical hypothyroidism. Endocrinol. Nutr. 59, 284–287 (2012)

    Article  PubMed  Google Scholar 

  15. R. Negro, A. Schwartz, R. Gismondi, A. Tinelli, T. Mangieri, A. Stagnaro-Green, Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J. Clin. Endocrinol. Metab. 96, E920–E924 (2011)

    Article  PubMed  CAS  Google Scholar 

  16. Z.Y. Shan, Y.Y. Chen, W.P. Teng, X.H. Yu, C.Y. Li, W.W. Zhou, B. Gao, J.R. Zhou, B. Ding, Y. Ma, Y. Wu, Q. Liu, H. Xu, W. Liu, J. Li, W.W. Wang, Y.B. Li, C.L. Fan, H. Wang, R. Guo, H.M. Zhang, A study for maternal thyroid hormone deficiency during the first half of pregnancy in China. Eur. J. Clin. Invest. 39, 37–42 (2009)

    Article  PubMed  CAS  Google Scholar 

  17. M. Centanni, Thyroxine treatment: absorption, malabsorption, and novel therapeutic approaches. Endocrine 43, 8–9 (2013)

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We acknowledge all persons who participated in this study. The study was supported by funding from the Healthcare Industry Special Project (200802008) and the Social Development Foundation of Liaoning Province (2007225010).

Conflict of interest

All contributing authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zhongyan Shan or Weiping Teng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, X., Chen, Y., Shan, Z. et al. The pattern of thyroid function of subclinical hypothyroid women with levothyroxine treatment during pregnancy. Endocrine 44, 710–715 (2013). https://doi.org/10.1007/s12020-013-9913-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-013-9913-2

Keywords

Navigation